Lexeo Therapeutics Q1 EPS $(0.25) Beats $(0.33) Estimate, Cash, Cash Equivalents And Investments Of $227.6M Expected To Provide Operational Runway Into 2028

Benzinga Newsdesk www.benzinga.com Positive 62.4%

Neg 0% Neu 0% Pos 62.4%

Comments

No comments yet. Be the first!